K2 HealthVentures Launches New Investment Company with Industry-Leading Team and $400 Million Initial Capital Commitment

— Will seek to advance development and fuel growth of life sciences
and healthcare companies with dual goals of profit and purpose —

BOSTON–(BUSINESS WIRE)–K2 HealthVentures (K2HV) announced today the launch of a new specialty
finance company that will provide long-term debt, equity, and
intellectual capital to private and public life sciences and healthcare
companies. With substantial initial funding and a permanent
capital base, which is expected to grow significantly over time, the
firm will initially target investments ranging in size from $10-50
million. A key principle of K2HV’s charter is its commitment to devoting
a portion of investment profits to fund underserved and underinvested
areas in the healthcare space, both in the US and globally.

With offices in Boston and New York, the K2HV investment team brings
together a unique combination of debt and equity investment expertise,
industry experience, and domain knowledge, along with a deep
understanding of the needs of innovative life sciences and healthcare
companies throughout their lifecycles. This diverse perspective and
relevant experience, coupled with strong networks and industry
connections, make K2HV an ideal long-term capital partner, as well as a
valued advisor on financing and growth strategies. The founding
leadership team has a substantial and successful track record in venture
and growth stage debt and equity investing, having committed over $2.5
billion to over 100 companies in the life sciences and healthcare space.

Announcing the launch of K2 HealthVentures, Parag Shah, Founding
Managing Director and CEO said, “We aim to provide more than
capital for life sciences and healthcare companies. We believe that for
growing companies to reach the next level, they need patient financial
support, proven business expertise, and a funding partner that
understands value and risk in this specialized space. K2HV embodies
these principles. And like the companies with which we hope to partner,
we are driven by both profit and purpose.”

K2 HealthVentures is backed by L1 Health, an international investment
firm with extensive experience in healthcare. Commenting on the launch,
L1 Health Partner and K2HV Founder and Board Chair Meghan FitzGerald
said, “The decision to back an industry-leading team to take this
venture forward was timely, as we believe the market need is ripe and
growing for creative financing to accelerate innovation in healthcare.
With substantial, long-term funding and some smart thinking around
science and technology innovation, we hope to improve the lives of
millions of patients.”

Founding Managing Director and CIO Anup Arora added, “L1 Health is an
ideal partner for us given their long-term investment focus and deep
experience in the healthcare space. Importantly, K2HV has patient,
permanent capital – with no fixed investment time horizons and no fund
cycles. This enables us to be truly long-term oriented and strategic in
our approach, and to adapt and grow our investments over time as our
partner companies grow.”

K2HV’s primary focus will be on customized debt financing, enabling
innovative companies to minimize equity dilution as they reach key
lifecycle milestones and build enterprise value. In addition, the firm
also has the ability to invest equity capital, thereby aligning its
long-term interests with those of its venture and public equity
investment partners. K2HV’s permanent capital, flexible approach, and
ability to invest across the balance sheet will confer a strong
competitive advantage, both for the firm and for its partner companies.

About K2 HealthVentures

K2 HealthVentures is an alternative investment firm focused on providing
flexible, long-term financing solutions to innovative private and public
companies in the life sciences and healthcare industries. The investment
team is comprised of collaborative, experienced professionals with
diverse backgrounds in finance and operations, as well as deep domain
knowledge across various healthcare sectors. A uniquely flexible,
permanent capital structure enables the firm to provide creative,
adaptive financing solutions and meet the evolving capital needs of its
portfolio companies as they grow. K2HV is driven by dual goals of Profit
and Purpose
– aiming to fuel the growth of innovative companies that
will ultimately improve the lives of patients and giving a percentage of
investment profits back to underserved areas in healthcare. www.k2hv.com.


K2 HealthVentures
Parag Shah

error: Content is protected !!